← FDA DRUG APPROVALS

FDA ANDA · ANDA214285

HALOBETASOL PROPIONATE

Sponsor: PERRIGO ISRAEL

APPLICATION
ANDA214285
TYPE
ANDA
ROUTE
UNKNOWN
DOSAGE FORM
UNKNOWN
MARKETING STATUS
None (Tentative Approval)

Products

HALOBETASOL PROPIONATENone (Tentative Approval)
HALOBETASOL PROPIONATE UNKNOWN · UNKNOWN · UNKNOWN

Approval history

2023-02-21UNKNOWN · Original · standardTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →